The global ECMO market accounted for USD 227.7 million in 2014 and is expected to reach USD 287.6 million by 2020 at a CAGR of 4.0% from 2015 to 2020. The purpose of the report published recently is to cover the definition, description, and forecast of Global Extracorporeal Membrane Oxygenation (ECMO) System market.
It involves deep dive analysis of market segmentation which comprises of submarkets, modality and application.
The report also offers strategic analysis of key players in the market. In this report, the extracorporeal membrane oxygenation (ECMO) system market is segmented on the basis of its modality and application.
In terms of modality, the market is segmented into Veno Artrial (VA), Veno Venous (VV), Artrio Venous (ECOO2 R).
Complete report on Extracorporeal Membrane Oxygenation (ECMO) Systems Market
Global extracorporeal membrane oxygenation (ECMO) system market is broadly classified on the basis of modality, applications and geography. Based on modality, the market is broadly segmented into Veno Artrial (VA), Veno Venous (VV), Artrio Venous (ECOO2 R).
However, by application, the market is segmented into Respiratory, Cardiac, and Extra-Corporeal Cardiopulmonary Resuscitation (ECPR).
The geographies covered in this report are North America, Europe, Asia-Pacific and rest of the world (RoW).
The market in North America accounted for the largest share in the global extracorporeal membrane oxygenation (ECMO) system market in 2014.
Globally, North America contributed to the largest Extracorporeal Membrane Oxygenation (ECMO) System market in 2014. The large share is attributed to rise in the increasing number of patients suffering from respiratory failure and cardiopulmonary disease, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), increasing adoption rate of ECMO machine in hospitals, technological advancements in ECMO system, success rate of ECMO and government initiatives and growing awareness towards ECMO. All these factors would help improve the demand of ECMO machines, which are used on a small scale in hospitals currently.
Furthermore, increasing number of patients suffering from respiratory failure and cardiopulmonary disease are other growth factors. With the rising number of cases globally, there is a boost in the growth of extra corporeal membrane oxygenators market. Respiratory failure may affect the muscles, nerves, bones, or tissues that support breathing, or they may affect the lungs directly. Over 3 million Canadians of all ages have a serious respiratory disease such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis (TB), cystic fibrosis, and respiratory distress syndrome. More than 5 million patients are admitted annually to ICUs in the U.S. In 2010, cardiovascular, lung, and blood diseases accounted for 1,017,000 deaths and 41 percent of all deaths in the U.S. However, cost of high end equipment, presence of conventional techniques, risk of complications, renal failure associated with ECMO are some of the restraints for the Extracorporeal Membrane Oxygenation (ECMO) System market.
Stakeholders of this research report
Respiratory care device manufacturers
Respiratory care device distributors
Healthcare institutions (hospitals, ICUs, ECMO centres)
Various research and consulting companies
Various research associations related to cardio-pulmonary care devices
Regulatory authorities such as FDA and insurance providers
Further more, increasing number of patients suffering from respiratory failure and cardiopulmonary disease are other growth factors. With the rising number of cases globally, there is a boost in the growth of extra corporeal membrane oxygenators market.
Respiratory failure may affect the muscles, nerves, bones, or tissues that support breathing, or they may affect the lungs directly. Over 3 million Canadians of all ages have a serious respiratory disease such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis (TB), cystic fibrosis, and respiratory distress syndrome.
More than 5 million patients are admitted annually to ICUs in the U.S.
CMO system is broadly segmented on basis of mortality and application. Based on mortality, global extracorporeal membrane oxygenation (ECMO) system market is classified into Veno-Arterial (VA), Veno-Venous (VV), and Artrio-Venous (AV).
Veno-arterial ECMO provides support to lungs and heart, and it is most preferred method. VA ECMO contributes the largest share in EMCO market, by modality.
Report also provides a detailed competitive landscaping of companies operating in this market. It also offers segment and country specific company shares, news & deals, M&A, segment specific pipeline products, product approvals and product recalls of major companies.
MAQUET Holding B.V. & CO. KG. (Germany), SORIN Group (Italy), MEDTRONIC (Republic of Ireland), NIPRO Medical Corporation (U.S.), Terumo Medical Corporation (Japan), MicroPort Scientific Corporation (China), Medos Medizintechnik AG (Germany) are some of the key players operating in this market.
Access this study “Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Modality (Veno -Arterial (VA), Veno -Venous (VV), Arterio-Venous (AV)), by Application (Respiratory, Cardiac, ECPR), by Geography – Global Forecast to 2020” research report
Research report covers basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities in the Extra corporeal Membrane Oxygenation (ECMO) System market.
source marketsandmarkets